caffeine has been researched along with MPTP Neurotoxicity Syndrome in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The caffeine pretreatment showed significant protection against the reduction of paw grip strength in MPTP treated mice." | 1.43 | Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A (13)C NMR study. ( Bagga, P; Chugani, AN; Patel, AB, 2016) |
| "Nicotine or caffeine-treated animals showed significant restoration against most of the MPTP-induced alterations." | 1.35 | Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. ( Nath, C; Patel, DK; Patel, S; Singh, C; Singh, K; Singh, MP; Singh, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Karuppagounder, SS | 1 |
| Uthaythas, S | 1 |
| Govindarajulu, M | 1 |
| Ramesh, S | 1 |
| Parameshwaran, K | 1 |
| Dhanasekaran, M | 1 |
| Bagga, P | 1 |
| Chugani, AN | 1 |
| Patel, AB | 1 |
| Xu, K | 1 |
| Di Luca, DG | 1 |
| Orrú, M | 1 |
| Xu, Y | 1 |
| Chen, JF | 1 |
| Schwarzschild, MA | 1 |
| Chen, X | 1 |
| Lan, X | 1 |
| Roche, I | 1 |
| Liu, R | 1 |
| Geiger, JD | 1 |
| Singh, K | 2 |
| Singh, S | 2 |
| Singhal, NK | 1 |
| Sharma, A | 1 |
| Parmar, D | 1 |
| Singh, MP | 2 |
| Patel, S | 1 |
| Patel, DK | 1 |
| Singh, C | 1 |
| Nath, C | 1 |
| Delle Donne, KT | 1 |
| Sonsalla, PK | 1 |
7 other studies available for caffeine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection.
Topics: Animals; Antioxidants; Behavior, Animal; Caffeine; Dietary Supplements; Dopaminergic Neurons; Mice; | 2021 |
Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A (13)C NMR study.
Topics: Amino Acids; Animals; Behavior, Animal; Brain; Caffeine; gamma-Aminobutyric Acid; Glucose; Hand Stre | 2016 |
Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Astrocytes; Caffeine; Dopamine; Dopaminergic Neurons; Fe | 2016 |
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Caffeine; Central Nervous System Stimulants; Cor | 2008 |
Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Base Sequence; Caffeine; Disease M | 2010 |
Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Caffeine; Central Nervo | 2008 |
Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation.
Topics: Adenosine; Animals; Caffeine; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; MPTP Poisoning | 1994 |